Natco Pharma gains 3% on $8 million investment in US biotech firm eGenesis
Natco Pharma shares rose nearly 3% after its Canadian subsidiary invested $8 million in US-based eGenesis, a biotech firm pioneering xenotransplantation. The deal enhances Natco’s presence in cutting-edge therapeutic programmes.